Entering text into the input field will update the search result below

Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q1 2020 Results - Earnings Call Transcript

May 06, 2020 12:03 PM ETAlexion Pharmaceuticals, Inc. (ALXN)1 Comment
SA Transcripts profile picture
SA Transcripts

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Q1 2020 Results Earnings Conference Call May 6, 2020 8:00 AM ET

Company Participants

Chris Stevo - Head of Investor Relations

Ludwig Hantson - Chief Executive Officer

Aradhana Sarin - Chief Financial Officer

John Orloff - Global Head of R&D

Brian Goff - Chief Commercial and Global Operations Officer

Conference Call Participants

Cory Kasimov - JPMorgan

Geoffrey Porges - SVB Leerink

Chris Raymond - Piper Sandler

Paul Matteis - Stifel

Geoff Meacham - Bank of America

Mohit Bansal - Citigroup

Phil Nadeau - Cowen & Company

Robyn Karnauskas - SunTrust

Matthew Harrison - Morgan Stanley


Ladies and gentlemen, thank you for standing by, and welcome to the Alexion Pharmaceuticals, Incorporated First Quarter 2020 Conference Call. At this time, all participant lines are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions]

At this time, I would like to hand the conference over to Mr. Chris Stevo, Head of Investor Relations.

Chris Stevo

Thank you, operator. Good morning. Thank you for joining us on today’s call to discuss Alexion’s performance for the first quarter of 2020. Today’s call will be led by Ludwig Hantson, our CEO. Ludwig will be joined by Aradhana Sarin, our Chief Financial Officer; John Orloff, our Global Head of R&D; and Brian Goff, our Chief Commercial and Global Operations Officer.

I will note that we are practicing physical distancing, and each will be doing the call from home. You can access the webcast slides that will be presented on this call by going to the Event Section of our Investor Relations page on our website.

Before we begin, I would like to point out that we will be making forward-looking statements, and these statements involve certain risks and uncertainties that could cause our actual results to differ

Recommended For You

Comments (1)

downlimit profile picture

As previously disclosed, we have been engaged in discussions with the SEC to resolve this investigation. Following March 31, 2020, we reached an agreement in principle with the SEC Enforcement Division staff to settle the claims relating to the SEC investigation, pursuant to which we would pay an aggregate amount less than $25 million to resolve the investigation. As a result, we have accrued a liability in such amount in our financial statements for the quarter ended March 31, 2020.
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.